Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 2

Status

Terminated 2Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Transfusion Reaction 1Thrombocytopenia 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Platelet Transfusion × Clear all
NCT00000589 2016-11-07

Trial to Reduce Alloimmunization to Platelets (TRAP)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
Other hematologic neoplasm

Hematologic Diseases, Leukemia, Myeloid, Acute

NCT00151866 2007-02-27

Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma

Sanquin Research & Blood Bank Divisions

Phase 3 Completed
180 enrolled
Classical hematology

Thrombocytopenia, Transfusion Reaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡